City
Epaper

50 pc tariffs by US bad policy move, India must continue to protect its farmers: SBI report

By IANS | Updated: August 8, 2025 10:44 IST

New Delhi, Aug 8 Imposition of 25 per cent penalty on goods trade with India, with a proposition ...

Open in App

New Delhi, Aug 8 Imposition of 25 per cent penalty on goods trade with India, with a proposition of additional 25 per cent on the world’s largest democracy, can be a bad policy decision for the US and its people, an SBI Research report said on Friday.

On the other hand, India — strategically protecting its sovereignty — must continue to protect its farmers from likelihood of predatory practices of select global conglomerates who may vie for a lucrative ‘Desi’ pie without investing in sustainable market infrastructure creation, anchoring agri value chain financing and being a partner in welfare schemes that upend ‘Ease of Living’ for our farming community, the report stressed.

Significantly, India has trumped global giants in milk production between 2015-2024.

In the year 2015, India's total milk production stood close to 155.5 million tonnes (EU 154.6 MT and US 94.6 MT).

When it comes to the pharmaceuticals market, India has been a cornerstone of the global supply chain for affordable, high-quality, essential medicines, particularly life saving oncology drugs, antibiotics, and chronic diseases' treatments.

“In the generic drug market, India supplies nearly 35 per cent of the pharmaceutical needs of the US. If the US shifts manufacturing and API production to other countries or domestic facilities, it will take minimum 3-5 years for meaningful capacity,” said the report.

In the US, health expenditure per person per annum is around $15,000, and hence with 35 per cent, India’s share in generic drugs tariff is going to impact US citizens significantly.

“Putting tariff on India pharma exports hurts the US objective of reducing the size of general government and goes against the objectives of DOGE. The US national health expenditures is 17.6 per cent of the GDP and the government-sponsored Medicare and Medicaid account for 36 per cent of the total expenditure,” said the report, adding that higher price of affordable medicines increase both expenditure under Medicare and Medicaid and also the out-of-pocket expenditure of private citizens.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

TechnologySouth Central Railway to expand coverage of CCTV surveillance system

NationalSouth Central Railway to expand coverage of CCTV surveillance system

HealthPatients falling ill from contaminated water in Indore rise to 66: MP Minister Vijayvargiya

National‘Spoke about Kerala govt’s interference in Karnataka, not about Keralites’: Deputy CM Shivakumar

NationalPatients falling ill from contaminated water in Indore rise to 66: MP Minister Vijayvargiya

National Realted Stories

NationalToo early to compare Khaleda Zia legacy with Tarique Rahman’s future India-stand

NationalRajasthan Cabinet approves vehicle scrapping policy

NationalMaha: BMC elections set to be a multi-cornered contest

NationalConcerns mount with China’s wargames around Taiwan after US pledges huge arms sale

NationalAquatic manoeuvres dominate Watermanship Training by Army’s Shatrujeet Brigade